Hollings Renton has an estimated net worth of $17.7 Million. This is based on reported shares across multiple companies, which include KYTHERA BIOPHARMACEUTICALS INC, Zymeworks Inc., RIGEL PHARMACEUTICALS INC, ANAPTYSBIO, INC, ONYX PHARMACEUTICALS INC, CEPHEID, Zymeworks Inc., AFFYMAX INC, PORTOLA PHARMACEUTICALS INC, and SANGSTAT MEDICAL CORP.

2006 was Hollings Renton's most active year for acquiring shares with 26 total transactions. Hollings Renton's most active month to acquire stocks was the month of March. 2004 was Hollings Renton's most active year for disposing of shares, totalling 149 transactions. Hollings Renton's most active month to dispose stocks was the month of January. 2007 saw Hollings Renton paying a total of $2,795,200.00 for 551,500 shares, this is the most they've acquired in one year. In 2007 Hollings Renton cashed out on 761,813 shares for a total of $9,395,876.76, their largest year based on trade value.